VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
OVID
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
OVIDOvid Therapeutics Inc.
$2.57$480M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOVIDQuarterly Cash Flow

Ovid Therapeutics Inc. (OVID) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Ovid Therapeutics Inc. (OVID) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

OVID Cash Flow Statement

Quarterly statement

OVID Cash Flow Statement

Ovid Therapeutics Inc. (OVID) cash flow statement — 12-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-17.59M-13.9M-10.41M-12.87M-4.77M-10.28M-10.01M-15.01M-14.26M-16.69M-11.91M-10.05M-11.71M-12.11M-9.18M-12.68M-13.29M-20.09M-12M-10.87M
Operating CF Margin %-2400.27%--1449.58%-9751.52%-76.12%-7907.69%-13168.42%-8674.57%-8434.91%-11274.32%-8388.95%-9221.1%-15607.14%-18351.91%-19826.56%-114180.99%--1389.71%--
Operating CF Growth %-268.54%-35.2%-4%14.23%66.51%38.39%15.99%-49.31%-21.78%-37.76%-29.82%20.71%11.91%39.7%23.53%-16.6%31.56%-112.48%17.31%-639.88%
Net Income-15.01M-16.99M9.66M-12.16M-4.68M-10.23M-9.25M-14.01M8.52M-11.69M-15.32M-11.25M-12.41M-13.36M-11.5M-11.97M-14.59M-16.11M-25.15M-11.38M
Depreciation & Amortization16K35K17K17K99K141K147K169K148K136K401.39K402.46K394.77K397.96K439.95K415.36K452.48K73.81K56.87K52.18K
Stock-Based Compensation1.43M01.2M01.22M1.28M01.31M01.97M1.79M1.63M001.73M01.72M1.32M01.16M
Deferred Taxes0000000000-105.41K346.35K00000000
Other Non-Cash Items-1.91M722K-21.42M960K-164K-167K-49K-733K-27.11M-5.36M-2.33M-1.21M1.34M1.12M225.64K1.24M612.17K-1.06M7.77M0
Working Capital Changes-2.13M2.33M134K-1.69M-1.24M-1.3M-853K-1.75M4.19M-1.74M3.65M28.98K-1.03M-270K-66.15K-2.37M-1.49M-4.31M5.33M-701.86K
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables-1.51M3.62M246K-2.24M2M-1.24M481K-2.01M1.12M-107K2.49M-2.55M1.93M-121.42K919.84K-3.58M2.36M-4.87M3.99M2.23M
Cash from Investing-86.74M5.95M-72.06M5.05M12.05M5.1M21.29M292K12.82M20.19M-48.52M-4.36M20.07M30.23M-4.17M-1.96M-80.68M-1.08M-161.96K-64.03K
Capital Expenditures0000004K4K-34K-19K-1.22K-5.25K-117.43K-13.56K-119.94K-18.6K-1.04M-76.17K-161.96K-22.05K
CapEx % of Revenue------5.26%2.31%20.12%12.84%0.86%4.81%156.58%20.55%259.16%167.54%-5.27%--
Acquisitions000000000048.5M4.35M0000000-48.1K
Investments--------------------
Other Investing0000001K0-116K0-48.5M-4.35M0056.94K0-221.11K-1M06.12K
Cash from Financing21.6M88.98M75.18M15K013K038K356K228K30.03M223.72K211.1K66.99K-43.6K81.63K109.55K33.08K109.18K549.05K
Debt Issued (Net)000000000030M000000000
Equity Issued (Net)21.6M88.98M75.18M15K013K038K356K228K33.39K223.72K211.1K66.99K081.63K033.08K130.49K0
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing00000000000000-43.6K0109.55K0-21.31K549.05K
Net Change in Cash-82.74M80.91M-7.46M-7.8M7.28M-5.17M11.28M-14.68M-1.08M3.73M-30.4M-14.19M8.57M18.18M-13.39M-14.55M-93.86M-21.13M-13.98M-10.39M
Free Cash Flow-17.59M-13.9M-10.41M-12.87M-4.77M-10.28M-10.03M-15M-14.29M-16.7M-11.91M-10.06M-11.71M-12.13M-9.24M-12.69M-14.55M-20.13M-12.16M-10.89M
FCF Margin %-2400.27%--1449.58%-9751.52%-76.12%-7907.69%-13197.37%-8672.25%-8455.03%-11287.16%-8389.81%-9225.91%-15617.53%-18372.45%-19962.68%-114348.5%--1392.89%--
FCF Growth %-268.54%-35.2%-3.77%14.2%66.59%38.46%15.81%-49.19%-21.99%-37.76%-28.95%20.79%19.5%39.77%24.03%-16.6%25.07%-112.51%16.71%-620.71%
FCF per Share-0.24-0.19-0.13-0.18-0.07-0.14-0.14-0.21-0.20-0.24-0.17-0.14-0.17-0.17-0.13-0.18-0.21-0.29-0.18-0.16
FCF Conversion (FCF/Net Income)1.17x0.82x-1.08x1.06x1.02x1.00x1.08x1.07x-1.67x1.43x0.78x0.89x0.94x0.91x0.80x1.06x0.91x1.25x0.48x0.96x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000